Hein, Simon http://orcid.org/0000-0002-9191-3264
Wilhelm, Konrad
Miernik, Arkadiusz
Schoenthaler, Martin
Suarez-Ibarrola, Rodrigo
Gratzke, Christian
Salem, Johannes
Karapanos, Leonidas
Netsch, Christopher
Becker, Benedikt
Secker, Armin
Veser, Julian
Neisius, Andreas
Fritsche, Hans-Martin
Schnabel, Marco Julius
Funding for this research was provided by:
Institutional funding, Faculty of Medicine, University of Freiburg, Germany
Article History
Received: 9 October 2019
Accepted: 6 March 2020
First Online: 21 March 2020
Compliance with ethical standards
:
: Simon Hein: German Federal Ministry of Education and Research, Berlin, GER—research funding Germany (unrelated to the present work). Rodrigo Suarez-Ibarrola: German Federal Ministry of Education and Research, Berlin, GER—research funding Germany (unrelated to the present work). Martin Schoenthaler: consultant contracts with NeoTract Inc., Pleasanton, USA and Trokamed GmbH, Geisingen, Germany (unrelated to the present work). Arkadiusz Miernik: German Federal Ministry of Education and Research, Berlin, GER—research funding, German Association of Urology, Düsseldorf, GER—travel sponsoring, European Association of Urology, Arnhem, NL—travel sponsoring, Walter de Gruyter, Berlin, GER—royalties, RichardWolf GmbH, Knittlingen, GER—speaker’s fee, KLS Martin, Tuttlingen, GER—advisor, Avatera medical, Jena, GER—advisor, Lisa laser OHG, GER—proctor, Schoelly fiberoptics GmbH, GER—advisor, Optimed GmbH, Ettlingen, GER—advisor (unrelated to the present work). Andreas Neisius: Boston Scientific GmbH, Ratingen, GER, consultant, Karl Storz GmbH, Tuttlingen, GER consultant, Richard Wolf GmbH, Knittlingen, GER, travel grants, advisor, Optimed GmbH, Ettlingen, GER, advisor (unrelated to the present work). Marco Schnabel: Advisory board Ipsen. Financial support as guest speaker: Janssen, Bristol-Myers-Squibb, Novartis, medac, Bayer, Roche, Dornier (all unrelated to the present work).
: Research involved human participants after informed consent in accordance to: IRB approved protocol number: IRB Number 16-101-0064 leading ethics committee: Ethik-Kommission University of Regensburg, Germany. German Clinical Trial Register ID: DRKS00016617 (approved WHO primary register).